These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36964579)

  • 1. Fibrin clot and Leukocyte-rich platelet-rich fibrin show similar release kinetics and amount of growth factors: a pilot study.
    Nakanishi Y; Matsushita T; Nagai K; Araki D; Hoshino Y; Kuroda R
    J Orthop Surg Res; 2023 Mar; 18(1):238. PubMed ID: 36964579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
    Schär MO; Diaz-Romero J; Kohl S; Zumstein MA; Nesic D
    Clin Orthop Relat Res; 2015 May; 473(5):1635-43. PubMed ID: 25690170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
    Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M
    Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced platelet rich fibrin demonstrates improved osteogenic induction potential in human periodontal ligament cells, growth factor production and mechanical properties as compared to leukocyte and platelet fibrin and injectable platelet rich fibrin.
    Shah R; M G T; Thomas R; A B TK
    Oral Maxillofac Surg; 2024 Mar; 28(1):413-424. PubMed ID: 37269407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept).
    El Bagdadi K; Kubesch A; Yu X; Al-Maawi S; Orlowska A; Dias A; Booms P; Dohle E; Sader R; Kirkpatrick CJ; Choukroun J; Ghanaati S
    Eur J Trauma Emerg Surg; 2019 Jun; 45(3):467-479. PubMed ID: 28324162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols.
    Fujioka-Kobayashi M; Katagiri H; Kono M; Schaller B; Zhang Y; Sculean A; Miron RJ
    Clin Oral Investig; 2020 Dec; 24(12):4373-4383. PubMed ID: 32382929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of incubation method on the release of growth factors in non-Ca
    Steller D; Herbst N; Pries R; Juhl D; Hakim SG
    J Craniomaxillofac Surg; 2019 Feb; 47(2):365-372. PubMed ID: 30578012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of centrifugation time on growth factor and MMP release of an experimental platelet-rich fibrin-type product.
    Eren G; Gürkan A; Atmaca H; Dönmez A; Atilla G
    Platelets; 2016 Jul; 27(5):427-32. PubMed ID: 26830681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor and proteinase profile of Vivostat® platelet-rich fibrin linked to tissue repair.
    Agren MS; Rasmussen K; Pakkenberg B; Jørgensen B
    Vox Sang; 2014 Jul; 107(1):37-43. PubMed ID: 24320875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of advanced platelet-rich fibrin on deep partial-thickness burn wounds in nude mice].
    Tang LJ; Li XM; Zhang XW; Luo Y; Xu G
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Aug; 39(8):771-778. PubMed ID: 37805789
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative release of growth factors from PRP, PRF, and advanced-PRF.
    Kobayashi E; Flückiger L; Fujioka-Kobayashi M; Sawada K; Sculean A; Schaller B; Miron RJ
    Clin Oral Investig; 2016 Dec; 20(9):2353-2360. PubMed ID: 26809431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Bielecki T; Jimbo R; Barbé G; Del Corso M; Inchingolo F; Sammartino G
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1145-52. PubMed ID: 21740377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro.
    He L; Lin Y; Hu X; Zhang Y; Wu H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):707-13. PubMed ID: 19836723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized Platelet-Rich Fibrin (PRF) from canine and feline origin: An analysis on its secretome pattern and architectural structure.
    Soares CS; Babo PS; Faria S; Pires MA; Carvalho PP
    Cytokine; 2021 Dec; 148():155695. PubMed ID: 34496340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Aspirin on Growth Factor Release From Freshly Isolated Leukocyte-Rich Platelet-Rich Plasma in Healthy Men: A Prospective Fixed-Sequence Controlled Laboratory Study.
    Jayaram P; Yeh P; Patel SJ; Cela R; Shybut TB; Grol MW; Lee BH
    Am J Sports Med; 2019 Apr; 47(5):1223-1229. PubMed ID: 30888847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparison of platelet-rich fibrin and platelet-rich plasma in releasing of growth factors and their effects on the proliferation and differentiation of adipose tissue-derived stem cells in vitro].
    Wang M; Li J; Liu J; Lin X; Xu W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2012 Dec; 30(6):641-4, 649. PubMed ID: 23330378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable platelet rich fibrin: cell content, morphological, and protein characterization.
    Varela HA; Souza JCM; Nascimento RM; Araújo RF; Vasconcelos RC; Cavalcante RS; Guedes PM; Araújo AA
    Clin Oral Investig; 2019 Mar; 23(3):1309-1318. PubMed ID: 30003342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Leukocyte- and Platelet-Rich Fibrin Block: Release of Growth Factors, Cellular Content, and Structure.
    Castro AB; Cortellini S; Temmerman A; Li X; Pinto N; Teughels W; Quirynen M
    Int J Oral Maxillofac Implants; 2019; 34(4):855–864. PubMed ID: 30742137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies.
    Dohan Ehrenfest DM; de Peppo GM; Doglioli P; Sammartino G
    Growth Factors; 2009 Feb; 27(1):63-9. PubMed ID: 19089687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte- and platelet-rich fibrin (L-PRF) for long-term delivery of growth factor in rotator cuff repair: review, preliminary results and future directions.
    Zumstein MA; Berger S; Schober M; Boileau P; Nyffeler RW; Horn M; Dahinden CA
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1196-206. PubMed ID: 21740372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.